Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence

Kelley Nicole Dages1, Olufemi Sofola-James2, Esha Sehanobish3, Prudhvi Regula3, Chien-Chang Chen1, Sergio Elias Chiarella1, Rohit Dilip Divekar1, Hillel W. Cohen3,4, Elina Jerschow1,3
1Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minn
2Department of International Medicine Programs, The George Washington University School of Medicine and Health Sciences, Washington, DC
3Division of Allergy & Immunology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
4Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.

Tài liệu tham khảo

Widal, 1993, Anaphylaxie Et Idiosyncrasie [Anaphylaxis and Idiosyncrasy]. 1992, Allergy Proc, 14, 373, 10.2500/108854193778774065 Samter, 1968, Intolerance to aspirin. Clinical studies and consideration of its pathogenesis, Ann Intern Med, 68, 975, 10.7326/0003-4819-68-5-975 Rajan, 2015, Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature, J Allergy Clin Immunol, 135, 676, 10.1016/j.jaci.2014.08.020 White, 2017, An update on the epidemiology of aspirin-exacerbated respiratory disease, Am J Rhinol Allergy, 31, 299, 10.2500/ajra.2017.31.4462 Feldman, 2019, Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease, J Asthma, 56, 731, 10.1080/02770903.2018.1490754 Koga, 2006, Characterisation of patients with frequent exacerbation of asthma, Respir Med, 100, 273, 10.1016/j.rmed.2005.05.017 Lee, 2007, Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study, Chest, 132, 1882, 10.1378/chest.07-0713 Mascia, 2005, Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma, J Allergy Clin Immunol, 116, 970, 10.1016/j.jaci.2005.08.035 Ta, 2015, Survey-defined patient experiences with aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 3, 711, 10.1016/j.jaip.2015.03.001 Berges-Gimeno, 2002, The natural history and clinical characteristics of aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 89, 474, 10.1016/S1081-1206(10)62084-4 Cahill, 2017, Automated identification of an aspirin-exacerbated respiratory disease cohort, J Allergy Clin Immunol, 139, 819, 10.1016/j.jaci.2016.05.048 Stevens, 2017, Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 5, 1061, 10.1016/j.jaip.2016.12.027 Szczeklik, 2000, Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma, Eur Respir J, 16, 432, 10.1034/j.1399-3003.2000.016003432.x Roland, 2019, Longitudinal progression of aspirin-exacerbated respiratory disease: analysis of a national insurance claims database, Int Forum Allergy Rhinol, 9, 1420, 10.1002/alr.22412 Stevens, 2021, J Allergy Clin Immunol, 147, 827, 10.1016/j.jaci.2020.10.043 D’Netto, 2023, During aspirin desensitization, omitting repeated provoking aspirin dose is safe, J Allergy Clin Immunol Pract, 11, 955, 10.1016/j.jaip.2022.11.040 Pelletier, 2019, Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease, J Allergy Clin Immunol Pract, 7, 1319, 10.1016/j.jaip.2018.08.004 Bensko, 2022, Pediatric-onset aspirin-exacerbated respiratory disease: clinical characteristics, prevalence, and response to dupilumab, J Allergy Clin Immunol Pract, 10, 2466, 10.1016/j.jaip.2022.05.016 Tuttle, 2016, Aspirin-exacerbated respiratory disease: not always “adult-onset”, J Allergy Clin Immunol Pract, 4, 756, 10.1016/j.jaip.2016.05.016 Nazario, 2022, Inequalities in asthma mortality by ethnicity and race in the United States and Puerto Rico, J Allergy Clin Immunol Pract, 10, 2178, 10.1016/j.jaip.2022.04.023 Castro-Rodriguez, 2016, Risk and protective factors for childhood asthma: what is the evidence?, J Allergy Clin Immunol Pract, 4, 1111, 10.1016/j.jaip.2016.05.003 Cowan, 2022, Uncontrolled asthma and household environmental exposures in Puerto Rico, J Asthma, 59, 427, 10.1080/02770903.2020.1858861 Forno, 2014, Obesity and adiposity indicators, asthma, and atopy in Puerto Rican children, J Allergy Clin Immunol, 133, 1308, 10.1016/j.jaci.2013.09.041 Rosenstreich, 1997, The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma, N Engl J Med, 336, 1356, 10.1056/NEJM199705083361904 Kshirsagar, 2020, Aspirin-exacerbated respiratory disease: longitudinal assessment of a large cohort and implications of diagnostic delay, Int Forum Allergy Rhinol, 10, 465, 10.1002/alr.22516 Houser, 2008, The role of allergy and smoking in chronic rhinosinusitis and polyposis, Laryngoscope, 118, 1521, 10.1097/MLG.0b013e31817d01b8 Lee, 2014, Cigarette smoke promotes eosinophilic inflammation, airway remodeling, and nasal polyps in a murine polyp model, Am J Rhinol Allergy, 28, 208, 10.2500/ajra.2014.28.4055 Chang, 2012, Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 108, 14, 10.1016/j.anai.2011.09.022